Your browser doesn't support javascript.
loading
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.
Witzig, T E; Tobinai, K; Rigacci, L; Ikeda, T; Vanazzi, A; Hino, M; Shi, Y; Mayer, J; Costa, L J; Bermudez Silva, C D; Zhu, J; Belada, D; Bouabdallah, K; Kattan, J G; Kuruvilla, J; Kim, W S; Larouche, J-F; Ogura, M; Ozcan, M; Fayad, L; Wu, C; Fan, J; Louveau, A-L; Voi, M; Cavalli, F.
Afiliación
  • Witzig TE; MayoClinic, Rochester, USA. Electronic address: witzig.thomas@mayo.edu.
  • Tobinai K; Department of Hematology, National Cancer Centre Hospital, Tokyo, Japan.
  • Rigacci L; Hematology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Ikeda T; Division of Hematology and Stem Cell Transplantation, Shizuoka Cancer Centre, Shizuoka, Japan.
  • Vanazzi A; Division of Clinical Hemato-Oncology, Istituto Europeo di Oncologia, Milan, Italy.
  • Hino M; Department of Clinical Hematology and Diagnostics, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Shi Y; Department of Medical Oncology, National Cancer Centre, Beijing; Cancer Hospital, Chinese Academy of Medical Sciences, Beijing; Peking Union Medical College, Beijing, China.
  • Mayer J; Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic.
  • Costa LJ; Department of Medicine, University of Alabama, Birmingham, USA; UAB-CCC, Bone Marrow Transplantation and Cell Therapy Program, University of Alabama, Birmingham, USA.
  • Bermudez Silva CD; Internal Medicine & Hematology, Instituto Nacional de Cancerologia, Bogota, Colombia.
  • Zhu J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China.
  • Belada D; Fourth Department of Internal Medicine-Hematology, University Hospital, Hradec Králové; Faculty of Medicine, Hradec Králové, Czech Republic.
  • Bouabdallah K; Department of Haematology, CHU Haut-Lévèque, Bordeaux, France.
  • Kattan JG; Department of Internal Medicine, Hotel Dieu de France University Hospital, Beirut, Lebanon.
  • Kuruvilla J; Princess Margaret Cancer Centre, Toronto, Canada.
  • Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul, South Korea.
  • Larouche JF; CHU de Quebec, Hôpital de l'Enfant Jésus, Quebec City, Canada.
  • Ogura M; Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
  • Ozcan M; Ankara University Medical Faculty, Ankara, Turkey.
  • Fayad L; University of Texas, Houston, USA; MD Anderson Cancer Center, Houston, USA.
  • Wu C; Oncology Clinical Development, Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Fan J; Oncology Clinical Development, Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Louveau AL; Novartis Pharma, Paris, France.
  • Voi M; Oncology Clinical Development, Novartis Pharmaceuticals Corporation, East Hanover, USA.
  • Cavalli F; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Ann Oncol ; 29(3): 707-714, 2018 03 01.
Article en En | MEDLINE | ID: mdl-29253068
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Quimioterapia Adyuvante / Everolimus / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Quimioterapia Adyuvante / Everolimus / Antineoplásicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article